Speech Drug Pricing Under the Trump Administration

Drug Pricing Under the Trump Administration

While President Trump has vowed to control drug costs under his administration, private payers and providers are acting now to address this through transparency mandates and outcome-based drug pricing. Learn the latest federal policy options for tackling rising drug costs and how your program can proactively plan for these changes. Be an active participant in the cost containment conversation before these changes are mandated from the top down.